Objective:To investigate the possible association between the phosphorylation of Akt andFASN expression in human osteosarcoma cell line U2-OS in vitro. As well as thepotential effects of the expression level of p-Akt and FASN on the malignantphenotype of osteosarcoma cell line U2-OS in vitro.Methods:Immunohistochemical staining was conducted on24OS specimens frompatients with pulmonary metastasis. The recombinant plasmid targeting FASN genewas constructed. An inhibitor of PI3K/Akt named LY294002was used in regulationof the expression level of p-Akt. Human U2-OS OS cells were treated withFASN-specific RNAi plasmid or LY294002, and normal U2-OS cells acting asnegative control group. The mRNA levels of Akt and FASN were measured byreal-time PCR. Western blot analysis was also performed to detect the proteinexperession of t-Akt, p-Akt and FASN. MTT assay was performed to examine cellproliferation; Transwell assay and Migration assay was used to evaluate the invasionand migration ability of U2-OS cells, respectively.Results:Immunohistochemical staining showed a significant positive correlation betweenphosphorylated Akt (p-Akt) and the expression of FASN (R=0.469, P=0.04). Theresults of RT-PCR and western blot demonstrated that the PI3K/Akt signalingpathway modulates FASN expression; the inhibition of FASN resulted in thedownregulation of p-Akt in the U2-OS cells. Furthermore, the proliferation assay, theinvasion assay and the migration assay showed us that the effects induced by theinhibition of the activity of p-Akt or FASN on the malignant phenotype of U2-OScells.Conclusion:The findings of our study suggest the existence of a positive feedback regulationbetween Akt phosphorylation and FASN expression and that this loop may play an important role in the malignant phenotype of OS cells. |